Crossref
Association Between Cystatin C and 1-Year Readmission Risk in Heart Failure Patients with or without Chronic Kidney Disease
Global Journal of Cardiovascular Diseases · 20.06.2026 · 5 (1) · 1-10
DOI: 10.31586/gjcd.2026.6378 ↗Kurz gefasst
Fachartikel in der Zeitschrift Global Journal of Cardiovascular Diseases, erschienen am 20.06.2026. Verfasst von Zi Lin und 1 weiteren Autor:innen.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Lin, Z., & Wei, M. (2026). Association Between Cystatin C and 1-Year Readmission Risk in Heart Failure Patients with or without Chronic Kidney Disease. Global Journal of Cardiovascular Diseases, 5(1), 1-10. https://doi.org/10.31586/gjcd.2026.6378
Vancouver
Lin Z, Wei M. Association Between Cystatin C and 1-Year Readmission Risk in Heart Failure Patients with or without Chronic Kidney Disease. Global Journal of Cardiovascular Diseases. 2026;5(1):1-10. doi:10.31586/gjcd.2026.6378
BibTeX
@article{Lin2026,
author = {Lin, Zi and Wei, Min},
title = {Association Between Cystatin C and 1-Year Readmission Risk in Heart Failure Patients with or without Chronic Kidney Disease},
journal = {Global Journal of Cardiovascular Diseases},
year = {2026},
volume = {5},
number = {1},
pages = {1--10},
doi = {10.31586/gjcd.2026.6378}
}
EUVIMED